Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Verve Therapeutics
< Previous
1
2
Next >
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
April 14, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
April 11, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose
March 24, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 03, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
January 13, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 03, 2025
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
November 05, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 02, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 03, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 01, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
June 28, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Leadership Update
May 31, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics to Participate in Upcoming Investor Conferences
May 30, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
May 08, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102
May 07, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Updates on its PCSK9 Program
April 02, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
From
Verve Therapeutics
Via
GlobeNewswire
Tickers
VERV
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.